Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 1 1

Status

Recruiting 8Unknown 6Completed 6Terminated 5Active not recruiting 5Not yet recruiting 2

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 26Lymphoid 8Head & Neck 6Thoracic 5Other solid neoplasm 5Breast 3Tumor-Agnostic 2Dermatologic 2Sarcoma 1Gynecologic 1Genitourinary 1

Conditions

Nasopharyngeal Carcinoma 3Nasopharyngeal Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 108Radiotherapy 45Docetaxel 44Radiotherapy, Intensity-Modulated 36Gemcitabine 31Fluorouracil 30camrelizumab 24toripalimab 21Drug Therapy 21Cetuximab 20apatinib 19Paclitaxel 16Carboplatin 16pembrolizumab 14Chemoradiotherapy 14Capecitabine 13Blood Specimen Collection 13sintilimab 12nimotuzumab 12Surveys and Questionnaires 10Surgical Procedures, Operative 10Endostatins 10Cyclophosphamide 9nedaplatin 8endostar protein 8durvalumab 8Nivolumab 8Neoadjuvant Therapy 8Induction Chemotherapy 8fludarabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × spartalizumab × Head & Neck × Clear all
NCT04557020 2024-05-01

Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC

Jiangxi Provincial Cancer Hospital

Phase 3 Unknown
200 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT03700476 2023-03-28

CONTINUUM

Sun Yat-sen University

Phase 3 Unknown
425 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT05097209 2023-03-23

Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Guilin Medical University, China

Phase 2 Unknown
200 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT04213404 2022-04-21

RISE-HN

National Taiwan University Hospital

Phase 1 Unknown
13 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05092217 2021-10-25

Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma

Eye & ENT Hospital of Fudan University

Phase 2 Unknown
80 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT03619824 2018-10-09

PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 2 Unknown
40 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡